Completed PHASE2 INTERVENTIONAL 6-arm NCT00959517

Trial of Artesunate Combination Therapy in Pakistan

Pseudo-randomised, Double-blinded Placebo-controlled Trial of Chloroquine or Sulphadoxine-pyrimethamine Alone or in Combination With Primaquine or Artesunate for the Treatment of Uncomplicated Falciparum Malaria in Pakistan

Sponsor: HealthNet TPO

Conditions Uncomplicated Falciparum Malaria

Interventions Chloroquine (CQ) artesunate (AS) primaquine (PQ) sulphadoxine-pyrimethamine (SP)

Updated 4 times since 2017 Last updated: Aug 13, 2009 Started: Jul 31, 2001 Primary completion: Jun 30, 2005 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Uncomplicated Falciparum Malaria and is currently completed. HealthNet TPO leads this study, which shows 4 recorded versions since 2001 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jul 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HealthNet TPO
London School of Hygiene and Tropical Medicine

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan